MabVax Therapeutics Lands $1,500,000 Series C Financing Round

  • Feed Type
  • Date
    7/9/2014
  • Company Name
    MabVax Therapeutics
  • Mailing Address
    11588 Sorrento Valley Road San Diego, CA 92121 USA
  • Company Description
    MabVax Therapeutics, Inc. is a San Diego, California based immunotherapeutics discovery and development company focused on developing and commercializing novel vaccines and human antibodies for the treatment of cancer.
  • Website
    http://www.mabvax.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,500,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    These follow-up transactions prior to the anticipated merger with Telik will help us continue to finance our lead monoclonal antibody product, 5B1, and our clinical stage cancer vaccine programs. We hope to see several of our programs achieve significant milestones in the next 24 to 30 months. Amount represents the sale of C-1 warrants.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.